Amneal Pharmaceuticals Q3 Revenue Estimate and EPS Forecast
Amneal Pharmaceuticals is expected to report Q3'26 results before the market opens on November 3. Revenue and EPS estimates were provided.
AMRX (Amneal Pharmaceuticals, Inc.) is set to announce its Q3'26 results on November 03, before the market opens. The earnings are expected to be disclosed at 9:30 AM ET (2:30 PM UTC).For Q3'26, revenue estimate is 814.02 million USD with EPS (earnings per share) anticipated at 0.24 USD. Learn more…